Journal Title：Critical Reviews In Therapeutic Drug Carrier Systems

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.

Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.

各種藥物載體系統的治療用途對許多慢性疾病的治療和潛在治愈具有重大影響，包括癌癥、糖尿病、牛皮癬、帕金森病、阿爾茨海默病、類風濕性關節炎、艾滋病毒感染、傳染病、哮喘和藥物成癮。這些領域的科學努力涉及物理、生物、醫學、制藥、生物材料和工程等領域。

有關該領域的文章出現在各種各樣的期刊上。隨著文章數量的大幅增加和科學的碎片化趨勢，跟上文獻的步伐并整理和評估數據的重要性和可靠性變得越來越困難，尤其是在涉及專有考慮的情況下。如果不額外閱讀原始文獻，摘要和非批判性文章通常無法為正確評估特定領域提供足夠可靠的基礎。本期刊通過發表權威、客觀、全面的多學科批判性評論論文來彌補這一差距，重點關注配方和給藥系統。受邀文章和投稿文章均需經過同行評審。

Critical Reviews In Therapeutic Drug Carrier Systems創刊于1984年，由Begell House Inc.出版商出版，收稿方向涵蓋藥學 - 醫學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。